The trial is set to start on 9 March and Its hard to believe that Dow didn’t have much contingencies in the R&H deal. It would be interesting case study for guys like us (deal makers). It's sad to think about employees of both companies if the deal is closed (I need to be neutral regarding this deal since I have many friends in both companies).
Anyway, now all assets of Dow on the table in effort to meet Rohm & Haas acquisition. No assets will be off the table in terms of possible sales as the company struggles to raise cash for its $18.8 billion acquisition of U.S. specialty chemical giant Rohm & Haas. Various reports indicate that Dow was in talks with private-equity firms including Blackstone and Kohlberg Kravis Roberts about selling a minority stake in Dow AgroSciences, and Syngenta was also said to be considering bidding for Dow AgroSciences if it went up for sale. ICIS news
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment